US Stock MarketDetailed Quotes

ELV Elevance Health

Watchlist
  • 389.250
  • -2.350-0.60%
Close Feb 14 16:00 ET
  • 389.250
  • 0.0000.00%
Post 20:01 ET
90.28BMarket Cap15.16P/E (TTM)

Elevance Health Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Assets
Total investments
0.95%37.18B
0.95%37.18B
15.59%40.35B
5.97%37.15B
8.20%37.63B
10.45%36.83B
10.45%36.83B
5.26%34.91B
5.17%35.06B
2.78%34.78B
-Equity investments
2,288.51%26.39B
2,288.51%26.39B
104.49%2.01B
37.82%1.44B
18.38%1.39B
-35.19%1.11B
-35.19%1.11B
-53.84%981M
-51.86%1.05B
-47.96%1.18B
-Short term investments
----
----
4.11%28.95B
3.14%28.9B
6.85%29.53B
14.11%29.61B
14.11%29.61B
8.95%27.81B
8.76%28.02B
5.40%27.64B
-Other invested assets
76.58%10.78B
76.58%10.78B
53.55%9.39B
13.63%6.81B
12.43%6.71B
7.42%6.11B
7.42%6.11B
10.91%6.12B
11.02%5.99B
11.30%5.97B
Cash and cash equivalents
27.00%8.29B
27.00%8.29B
-27.96%7.87B
-34.97%6.5B
-38.61%6.23B
-11.66%6.53B
-11.66%6.53B
23.07%10.92B
54.76%9.99B
64.62%10.14B
Receivables
5.21%18.8B
5.21%18.8B
8.66%18.4B
16.31%19.22B
9.47%18.29B
11.35%17.87B
11.35%17.87B
19.19%16.93B
16.35%16.52B
13.97%16.71B
-Accounts receivable
137.86%18.8B
137.86%18.8B
-8.55%7.21B
8.20%8.04B
-25.77%8.93B
11.56%7.9B
11.56%7.9B
-25.32%7.88B
-29.90%7.43B
6.21%12.03B
-Other receivables
----
----
23.66%11.19B
22.94%11.18B
100.13%9.36B
11.18%9.96B
11.18%9.96B
147.85%9.05B
152.56%9.09B
40.31%4.68B
Net PPE
6.72%4.65B
6.72%4.65B
6.05%4.51B
-2.13%4.45B
0.75%4.45B
1.00%4.36B
1.00%4.36B
1.22%4.25B
11.17%4.55B
10.84%4.42B
Goodwill and other intangible assets
13.43%40.37B
13.43%40.37B
1.43%36.29B
1.20%36.41B
1.30%36.66B
2.57%35.59B
2.57%35.59B
2.48%35.78B
2.41%35.98B
3.87%36.19B
-Goodwill
----
----
2.67%25.97B
2.72%25.96B
2.67%25.95B
3.83%25.32B
3.83%25.32B
3.73%25.29B
3.72%25.27B
4.21%25.27B
-Other intangible assets
----
----
-1.58%10.33B
-2.39%10.45B
-1.88%10.71B
-0.41%10.27B
-0.41%10.27B
-0.43%10.49B
-0.55%10.7B
3.09%10.92B
Assets of discontinued operations
--490M
--490M
--565M
--601M
----
----
----
----
----
----
Other assets
-11.12%6.9B
-11.12%6.9B
11.25%8.55B
22.51%8.66B
26.96%8.63B
11.39%7.76B
11.39%7.76B
0.26%7.69B
-7.75%7.07B
-2.80%6.8B
Total assets
7.11%116.67B
7.11%116.67B
5.48%116.53B
3.50%112.99B
2.62%111.89B
6.01%108.93B
6.01%108.93B
7.23%110.48B
8.22%109.17B
8.51%109.04B
Liabilities
Policy holders liabilities reserve
----
----
-28.33%4.65B
-22.47%5.23B
-12.24%6.06B
-5.31%6.38B
-5.31%6.38B
2.87%6.49B
5.50%6.75B
11.31%6.91B
Payables
-32.12%15.63B
-32.12%15.63B
-2.52%21.6B
-1.10%20.96B
7.36%22.12B
8.57%23.02B
8.57%23.02B
9.67%22.16B
1.05%21.2B
1.95%20.6B
-Accounts payable
-32.12%15.63B
-32.12%15.63B
-2.52%21.6B
-1.10%20.96B
7.36%22.12B
8.57%23.02B
8.57%23.02B
9.67%22.16B
1.05%21.2B
1.95%20.6B
Short term debt and capital lease obligation
7.47%2.01B
7.47%2.01B
207.88%2.46B
1,079.25%3.13B
1,588.68%4.48B
6.18%1.87B
6.18%1.87B
-68.22%799M
-89.06%265M
-92.14%265M
-Current debt
7.47%2.01B
7.47%2.01B
207.88%2.46B
1,079.25%3.13B
1,588.68%4.48B
6.18%1.87B
6.18%1.87B
-68.22%799M
-89.06%265M
-92.14%265M
Current deferred liabilities
----
----
-58.61%1.79B
-66.78%1.48B
-66.45%1.47B
26.08%1.4B
26.08%1.4B
17.02%4.33B
359.11%4.46B
263.14%4.39B
Long term debt and capital lease obligation
25.69%29.22B
25.69%29.22B
2.67%24.69B
-1.20%24.56B
-12.80%21.98B
4.01%23.25B
4.01%23.25B
13.11%24.05B
17.45%24.86B
26.75%25.2B
-Long term debt
25.69%29.22B
25.69%29.22B
2.67%24.69B
-1.20%24.56B
-12.80%21.98B
4.01%23.25B
4.01%23.25B
13.11%24.05B
17.45%24.86B
26.75%25.2B
Non current deferred liabilities
----
----
17.59%2.09B
9.99%2.04B
8.48%2.2B
-2.23%1.97B
-2.23%1.97B
-2.52%1.78B
-8.36%1.85B
-13.62%2.03B
Other liabilities
144.06%28.39B
144.06%28.39B
24.58%15.37B
15.83%13.29B
5.72%12.88B
3.44%11.63B
3.44%11.63B
10.43%12.34B
3.79%11.47B
8.49%12.18B
Total liabilities
8.23%75.25B
8.23%75.25B
0.99%72.65B
-0.23%70.69B
-0.55%71.18B
4.66%69.52B
4.66%69.52B
7.40%71.94B
8.99%70.86B
11.05%71.58B
Shareholders'equity
Share capital
----
----
0.00%2M
0.00%2M
0.00%2M
0.00%2M
0.00%2M
0.00%2M
0.00%2M
0.00%2M
-common stock
----
----
0.00%2M
0.00%2M
0.00%2M
0.00%2M
0.00%2M
0.00%2M
0.00%2M
0.00%2M
-Preferred stock
----
----
--0
--0
--0
--0
--0
--0
--0
--0
Paid-in capital
----
----
3.11%9.11B
2.74%9B
2.14%8.88B
-2.38%8.87B
-2.38%8.87B
-3.70%8.83B
-4.08%8.76B
-4.96%8.7B
Retained earnings
----
----
9.51%35.16B
9.39%34.58B
7.75%33.09B
7.09%31.75B
7.09%31.75B
8.44%32.1B
9.65%31.61B
9.44%30.71B
Gains losses not affecting retained earnings
----
----
80.53%-489M
35.96%-1.39B
33.41%-1.37B
47.27%-1.31B
47.27%-1.31B
9.77%-2.51B
-0.79%-2.17B
-65.86%-2.05B
Total stockholders'equity
5.11%41.32B
5.11%41.32B
13.93%43.78B
10.43%42.19B
8.71%40.61B
8.45%39.31B
8.45%39.31B
6.76%38.42B
6.68%38.21B
3.84%37.36B
Noncontrolling interests
12.12%111M
12.12%111M
-10.34%104M
-0.93%106M
-1.92%102M
13.79%99M
13.79%99M
123.08%116M
94.55%107M
85.71%104M
Total equity
5.13%41.43B
5.13%41.43B
13.86%43.88B
10.40%42.3B
8.68%40.71B
8.46%39.41B
8.46%39.41B
6.93%38.54B
6.82%38.31B
3.97%37.46B
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Assets
Total investments 0.95%37.18B0.95%37.18B15.59%40.35B5.97%37.15B8.20%37.63B10.45%36.83B10.45%36.83B5.26%34.91B5.17%35.06B2.78%34.78B
-Equity investments 2,288.51%26.39B2,288.51%26.39B104.49%2.01B37.82%1.44B18.38%1.39B-35.19%1.11B-35.19%1.11B-53.84%981M-51.86%1.05B-47.96%1.18B
-Short term investments --------4.11%28.95B3.14%28.9B6.85%29.53B14.11%29.61B14.11%29.61B8.95%27.81B8.76%28.02B5.40%27.64B
-Other invested assets 76.58%10.78B76.58%10.78B53.55%9.39B13.63%6.81B12.43%6.71B7.42%6.11B7.42%6.11B10.91%6.12B11.02%5.99B11.30%5.97B
Cash and cash equivalents 27.00%8.29B27.00%8.29B-27.96%7.87B-34.97%6.5B-38.61%6.23B-11.66%6.53B-11.66%6.53B23.07%10.92B54.76%9.99B64.62%10.14B
Receivables 5.21%18.8B5.21%18.8B8.66%18.4B16.31%19.22B9.47%18.29B11.35%17.87B11.35%17.87B19.19%16.93B16.35%16.52B13.97%16.71B
-Accounts receivable 137.86%18.8B137.86%18.8B-8.55%7.21B8.20%8.04B-25.77%8.93B11.56%7.9B11.56%7.9B-25.32%7.88B-29.90%7.43B6.21%12.03B
-Other receivables --------23.66%11.19B22.94%11.18B100.13%9.36B11.18%9.96B11.18%9.96B147.85%9.05B152.56%9.09B40.31%4.68B
Net PPE 6.72%4.65B6.72%4.65B6.05%4.51B-2.13%4.45B0.75%4.45B1.00%4.36B1.00%4.36B1.22%4.25B11.17%4.55B10.84%4.42B
Goodwill and other intangible assets 13.43%40.37B13.43%40.37B1.43%36.29B1.20%36.41B1.30%36.66B2.57%35.59B2.57%35.59B2.48%35.78B2.41%35.98B3.87%36.19B
-Goodwill --------2.67%25.97B2.72%25.96B2.67%25.95B3.83%25.32B3.83%25.32B3.73%25.29B3.72%25.27B4.21%25.27B
-Other intangible assets ---------1.58%10.33B-2.39%10.45B-1.88%10.71B-0.41%10.27B-0.41%10.27B-0.43%10.49B-0.55%10.7B3.09%10.92B
Assets of discontinued operations --490M--490M--565M--601M------------------------
Other assets -11.12%6.9B-11.12%6.9B11.25%8.55B22.51%8.66B26.96%8.63B11.39%7.76B11.39%7.76B0.26%7.69B-7.75%7.07B-2.80%6.8B
Total assets 7.11%116.67B7.11%116.67B5.48%116.53B3.50%112.99B2.62%111.89B6.01%108.93B6.01%108.93B7.23%110.48B8.22%109.17B8.51%109.04B
Liabilities
Policy holders liabilities reserve ---------28.33%4.65B-22.47%5.23B-12.24%6.06B-5.31%6.38B-5.31%6.38B2.87%6.49B5.50%6.75B11.31%6.91B
Payables -32.12%15.63B-32.12%15.63B-2.52%21.6B-1.10%20.96B7.36%22.12B8.57%23.02B8.57%23.02B9.67%22.16B1.05%21.2B1.95%20.6B
-Accounts payable -32.12%15.63B-32.12%15.63B-2.52%21.6B-1.10%20.96B7.36%22.12B8.57%23.02B8.57%23.02B9.67%22.16B1.05%21.2B1.95%20.6B
Short term debt and capital lease obligation 7.47%2.01B7.47%2.01B207.88%2.46B1,079.25%3.13B1,588.68%4.48B6.18%1.87B6.18%1.87B-68.22%799M-89.06%265M-92.14%265M
-Current debt 7.47%2.01B7.47%2.01B207.88%2.46B1,079.25%3.13B1,588.68%4.48B6.18%1.87B6.18%1.87B-68.22%799M-89.06%265M-92.14%265M
Current deferred liabilities ---------58.61%1.79B-66.78%1.48B-66.45%1.47B26.08%1.4B26.08%1.4B17.02%4.33B359.11%4.46B263.14%4.39B
Long term debt and capital lease obligation 25.69%29.22B25.69%29.22B2.67%24.69B-1.20%24.56B-12.80%21.98B4.01%23.25B4.01%23.25B13.11%24.05B17.45%24.86B26.75%25.2B
-Long term debt 25.69%29.22B25.69%29.22B2.67%24.69B-1.20%24.56B-12.80%21.98B4.01%23.25B4.01%23.25B13.11%24.05B17.45%24.86B26.75%25.2B
Non current deferred liabilities --------17.59%2.09B9.99%2.04B8.48%2.2B-2.23%1.97B-2.23%1.97B-2.52%1.78B-8.36%1.85B-13.62%2.03B
Other liabilities 144.06%28.39B144.06%28.39B24.58%15.37B15.83%13.29B5.72%12.88B3.44%11.63B3.44%11.63B10.43%12.34B3.79%11.47B8.49%12.18B
Total liabilities 8.23%75.25B8.23%75.25B0.99%72.65B-0.23%70.69B-0.55%71.18B4.66%69.52B4.66%69.52B7.40%71.94B8.99%70.86B11.05%71.58B
Shareholders'equity
Share capital --------0.00%2M0.00%2M0.00%2M0.00%2M0.00%2M0.00%2M0.00%2M0.00%2M
-common stock --------0.00%2M0.00%2M0.00%2M0.00%2M0.00%2M0.00%2M0.00%2M0.00%2M
-Preferred stock ----------0--0--0--0--0--0--0--0
Paid-in capital --------3.11%9.11B2.74%9B2.14%8.88B-2.38%8.87B-2.38%8.87B-3.70%8.83B-4.08%8.76B-4.96%8.7B
Retained earnings --------9.51%35.16B9.39%34.58B7.75%33.09B7.09%31.75B7.09%31.75B8.44%32.1B9.65%31.61B9.44%30.71B
Gains losses not affecting retained earnings --------80.53%-489M35.96%-1.39B33.41%-1.37B47.27%-1.31B47.27%-1.31B9.77%-2.51B-0.79%-2.17B-65.86%-2.05B
Total stockholders'equity 5.11%41.32B5.11%41.32B13.93%43.78B10.43%42.19B8.71%40.61B8.45%39.31B8.45%39.31B6.76%38.42B6.68%38.21B3.84%37.36B
Noncontrolling interests 12.12%111M12.12%111M-10.34%104M-0.93%106M-1.92%102M13.79%99M13.79%99M123.08%116M94.55%107M85.71%104M
Total equity 5.13%41.43B5.13%41.43B13.86%43.88B10.40%42.3B8.68%40.71B8.46%39.41B8.46%39.41B6.93%38.54B6.82%38.31B3.97%37.46B
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
XINGANJIANG
873167
+30.00%
INNOVATIVE DATA
835305
+29.98%
CHENGUANG MEDICAL
430300
+29.96%
4
Hangzhou Gaoxin Materials Technology
300478
+20.04%
5
Beijing Philisense Technology
300287
+20.03%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Earnings Season Underway
Earnings season is here. What to know?
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
TSLA earnings preview: Grab rewards by guessing the opening price!